Dimitra Karagkouni

Dr. Dimitra Karagkouni


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DKDimitra Karagkouni
Dimitra Karagkouni
MPMaria D Paraskevopoulou
Maria D Paraskevopoulou
STSpyros Tastsoglou
Spyros Tastsoglou
GSGiorgos Skoufos
Giorgos Skoufos
AKAnna Karavangeli
Anna Karavangeli
Artemis G. HatzigeorgiouArtemis G. Hatzigeorgiou
Artemis G. Hatzigeorgiou
DIANA-LncBase v3.0 (www.microrna.gr/LncBase) is a reference repository with experimentally supported miRNA targets on non-coding transcripts. Its third version provides approximately half a million entries, corresponding to ∼240 000 unique tissue and cell type specific miRNA–lncRNA pairs. This compilation of interactions is derived from the manual curation of publications and the analysis of >300 high-throughput datasets. miRNA targets are supported by 14 experimental methodologies, applied to 243 distinct cell types and tissues in human and mouse. The largest part of the database is highly confident, AGO-CLIP-derived miRNA-binding events. LncBase v3.0 is the first relevant database to employ a robust CLIP-Seq-guided algorithm, microCLIP framework, to analyze 236 AGO-CLIP-Seq libraries and catalogue ∼370 000 miRNA binding events. The database was redesigned from the ground up, providing new functionalities. Known short variant information, on >67,000 experimentally supported target sites and lncRNA expression profiles in different cellular compartments are catered to users. Interactive visualization plots, portraying correlations of miRNA–lncRNA pairs, as well as lncRNA expression profiles in a wide range of cell types and tissues, are presented for the first time through a dedicated page. LncBase v3.0 constitutes a valuable asset for ncRNA research, providing new insights to the understanding of the still widely unexplored lncRNA functions.

21 August 2021
Verified
Book Chapter
Closed access
PDF file
DKDimitra Karagkouni
Dimitra Karagkouni
AKAnna Karavangeli
Anna Karavangeli
MPMaria D. Paraskevopoulou
Maria D. Paraskevopoulou
Artemis G. HatzigeorgiouArtemis G. Hatzigeorgiou
Artemis G. Hatzigeorgiou

22 June 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MMMaritsa Margaroni
Maritsa Margaroni
Maria AgallouMaria Agallou
Maria Agallou
AVAthina Vasilakaki
Athina Vasilakaki
DKDimitra Karagkouni
Dimitra Karagkouni
GSGiorgos Skoufos
Giorgos Skoufos
EKEvdokia Karagouni
Evdokia Karagouni
Leishmania parasites are capable of effectively invading dendritic cells (DCs), a cell population orchestrating immune responses against several diseases, including leishmaniasis, by bridging innate and adaptive immunity. Leishmania on the other hand has evolved various mechanisms to subvert DCs activation and establish infection. Thus, the transcriptional profile of DCs derived from bone marrow (BMDCs) that have been infected with Leishmania infantum parasite or of DCs exposed to chemically inactivated parasites was investigated via RNA sequencing, aiming to better understand the host–pathogen interplay. Flow cytometry analysis revealed that L. infantum actively inhibits maturation of not only infected but also bystander BMDCs. Analysis of double-sorted L. infantum infected BMDCs revealed significantly increased expression of genes mainly associated with metabolism and particularly glycolysis. Moreover, differentially expressed genes (DEGs) related to DC-T cell interactions were also found to be upregulated exclusively in infected BMDCs. On the contrary, transcriptome analysis of fixed parasites containing BMDCs indicated that energy production was mediated through TCA cycle and oxidative phosphorylation. In addition, DEGs related to differentiation of DCs leading to activation and differentiation of Th17 subpopulations were detected. These findings suggest an important role of metabolism on DCs-Leishmania interplay and eventually disease establishment.

30 December 2020 in Genes
Verified
Journal Article
Open access
PDF file
AAAthanasios Alexiou
Athanasios Alexiou
Dimitrios ZisisDimitrios Zisis
Dimitrios Zisis
IKIoannis Kavakiotis
Ioannis Kavakiotis
MMMarios Miliotis
Marios Miliotis
AKAntonis Koussounadis
Antonis Koussounadis
Artemis G. HatzigeorgiouArtemis G. Hatzigeorgiou
Artemis G. Hatzigeorgiou
MicroRNAs (miRNAs) are small non-coding RNAs (~22 nts) that are considered central post-transcriptional regulators of gene expression and key components in many pathological conditions. Next-Generation Sequencing (NGS) technologies have led to inexpensive, massive data production, revolutionizing every research aspect in the fields of biology and medicine. Particularly, small RNA-Seq (sRNA-Seq) enables small non-coding RNA quantification on a high-throughput scale, providing a closer look into the expression profiles of these crucial regulators within the cell. Here, we present DIANA-microRNA-Analysis-Pipeline (DIANA-mAP), a fully automated computational pipeline that allows the user to perform miRNA NGS data analysis from raw sRNA-Seq libraries to quantification and Differential Expression Analysis in an easy, scalable, efficient, and intuitive way. Emphasis has been given to data pre-processing, an early, critical step in the analysis for the robustness of the final results and conclusions. Through modularity, parallelizability and customization, DIANA-mAP produces high quality expression results, reports and graphs for downstream data mining and statistical analysis. In an extended evaluation, the tool outperforms similar tools providing pre-processing without any adapter knowledge. Closing, DIANA-mAP is a freely available tool. It is available dockerized with no dependency installations or standalone, accompanied by an installation manual through Github.

22 November 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
EZElissavet Zacharopoulou
Elissavet Zacharopoulou
MPMaria D Paraskevopoulou
Maria D Paraskevopoulou
STSpyros Tastsoglou
Spyros Tastsoglou
AAAthanasios Alexiou
Athanasios Alexiou
AKAnna Karavangeli
Anna Karavangeli
DKDimitra Karagkouni
Dimitra Karagkouni
MicroRNAs (miRNAs) are central post-transcriptional gene expression regulators in healthy and diseased states. Despite decades of effort, deciphering miRNA targets remains challenging, leading to an incomplete miRNA interactome and partially elucidated miRNA functions. Here, we introduce microT-CNN, an avant-garde deep convolutional neural network model that moves the needle by integrating hundreds of tissue-matched (in-)direct experiments from 26 distinct cell types, corresponding to a unique training and evaluation set of >60 000 miRNA binding events and ~30 000 unique miRNA–gene target pairs. The multilayer sequence-based design enables the prediction of both host and virus-encoded miRNA interactions, providing for the first time up to 67% of direct genuine Epstein–Barr virus– and Kaposi’s sarcoma–associated herpesvirus–derived miRNA–target pairs corresponding to one out of four binding events of virus-encoded miRNAs. microT-CNN fills the existing gap of the miRNA–target prediction by providing functional targets beyond the canonical sites, including 3′ compensatory miRNA pairings, prompting 1.4-fold more validated miRNA binding events compared to other implementations and shedding light on previously unexplored facets of the miRNA interactome.